No Data
No Data
No Data
No Data
No Data
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, May 2, 2024, following the release of its first quarter 2024 financial
BusinesswireApr 18 16:15 ET
Puma Biotechnology (NASDAQ:PBYI) Shareholders Have Earned a 93% Return Over the Last Year
Yahoo FinanceApr 8 11:02 ET
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced that on April 2, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit
BusinesswireApr 3 17:30 ET
Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
Yahoo FinanceMar 22 07:53 ET
Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise
Puma Biotechnology (PBYI) said Wednesday that it intends to begin a phase 2 breast cancer study that will evaluate alisertib in combination with endocrine treatment in the second half of 2024. The com
MT NewswiresMar 20 11:18 ET
Puma Biotech Cleared to Trial Takeda-partnered Breast Cancer Therapy in U.S.
Seeking AlphaMar 20 10:06 ET
loading...
Stock_Drift : Good call!!!! I’ve traded it before but it’s ????
SlowndEasyWinsOP Stock_Drift: I made some on this before but due to rush entry it’s frustrating still on watch though I am not attached with gain or loss , time to practice let opportunities come themselves
Stock_Drift SlowndEasyWinsOP: I concur.
No Data
No Data